Drug eluting stents: From evidence based medicine to clinical practice;Les stents à élution de médicaments: Preuves, incertitudes et pratiques

Annales de Cardiologie et d'Angeiologie

Volumn 54, Issue 4, 2005, Pages 201-211

  Philippe, F ^a   Dibie, A ^a   Larrazet, F ^a   Meziane, T ^a   Folliguet, T ^a   Laborde, F ^a  

^a INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

Drug eluting stents; Guidelines

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIMITOTIC AGENT; BATIMASTAT; CORTICOSTEROID; DACTINOMYCIN; ESTRADIOL; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; TRANILAST; ANTHRANILIC ACID DERIVATIVE; ANTITHROMBOCYTIC AGENT; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

CLINICAL PRACTICE; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; FOLLOW UP; HUMAN; LONG TERM CARE; MORTALITY; PRACTICE GUIDELINE; RESTENOSIS; REVIEW; RISK ASSESSMENT; CLINICAL TRIAL; ECONOMICS; STENT;

ANTHRANILIC ACIDS; CLINICAL TRIALS; CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; SIROLIMUS; STENTS; TACROLIMUS;

EID: 23044457637     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2005.05.016     Document Type: Short Survey

References (23)

1. P.W. Serruys, P. de Jaegere, and F. Kiemeneij A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent study group N. Engl. J. Med. 331 1994 489 495
2. D.L. Fischman, M.B. Leon, and D. Baim A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent restenosis study investigators N. Engl. J. Med. 331 1994 496 501
3. D.E. Cutlip, S.B. Baim, and K.K. Ho Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
4. S.O. Marx, and A.R. Marks Bench to bedside: the development of rapamycin and its application to stent restenosis Circulation 104 2001 852 855
5. J.E. Sousa, M.A. Costa, and A.C. Abizaid Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up Circulation 104 2001 2007 2011
6. M. Degertekin, P.W. Serruys, and D.P. Foley Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2:years) clinical, angiographic, and intravascular ultrasound follow-up Circulation 106 2002 1610 1613
7. J.E. Sousa, M.A. Costa, and A.G. Sousa Two-year angiographic and intravascular ultrsond follow-up afeter implantation of sirolimus-eluting stents in human coronary arteries Circulation 107 2003 381 383
8. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N. Engl. J. Med. 346 2002 1773 1780
9. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stent vs standard stents in patients with stenosis in a native coronary artery N. Engl. J. Med. 349 2003 1315 1323
10. D.R. Holmes Jr., M.B. Leon, and J.W. Moses Analysis of 1-year clinical outcomes in the SIRIUS Trial: A randomized trial of a sirolimus-eluting stent vs a standard stent in patients at high risk for coronary restenosis Circulation 109 2004 634 640
11. J. Schofer, M. Schluter, and A.H. Gershlick Sirolimus-eluting stent for the treatment of patients with long atherosclerotic lesions in small coronary arteries double blind randomized controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
12. E. Schampaert, E.A. Cohen, and M. Schlüter The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J. Am. Coll. Cardiol. 43 2004
13. P.W. Serruys, M. Degertekin, and K. Tanabe For the TAXUS II study group vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial Circulation 109 2004 627 633
14. A. Gershlick, I. De Scheerder, and B. Chevalier Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the european evaluation of paclitaxel eluting stent (ELUTES) Trial Circulation 109 2004 487 493
15. V. Mathew, B.J. Gersh, and B.A. Williams Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the prevention of restenosis with tranilast and its outcomes (PRESTO) Circulation 109 2004 476 480
16. A. Abizaid, M. Albertal, and M.A. Costa First human experience with the 17-beta-estradiol-eluting stent. The estrogen and stents to eliminate restenosis (EASTER) trial J. Am. Coll. Cardiol. 43 2004
17. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
18. A. Colombo, J.W. Moses, and M.C. Morice Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions Circulation 109 2004 1244 1249
19. B.A. Van Hout, W.K. Lindeboom, and M.C. Morice Cost-effectiveness of the sirolimus-eluting BX Velocity stent: one year results Eur. Heart J. 4 suppl. abstract 2002 691
20. B. Chevalier, H. Eltchaninoff, and D. Blanchard De l'usage des endoproth̀ses coronaires Arch. Mal. Cœur 96 2003 163 174
21. E. Regar, P.W. Serruys, and C. Bode Angiographic findings of the multicenter randomized study with the sirolimus-eluting Bx Velocity balloon-expandable stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size Circulation 106 2002 1949 1956
22. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N. Engl. J. Med. 345 2001 494 502
23. S.R. Steinhubl, P.B. Berger, and J.T. Mann 3rd Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420